Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Antithrombogenic Heparin Coating Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Antithrombogenic Heparin Coating Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Medical Devices & Consumables
Published Date: 2026-03-24
Pages: 150 Pages
Report ld: 6274079
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Antithrombogenic Heparin Coating Market Size(US$)
CAGR 2026-2032
9.2%
Market Size,2032
USD 306
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 181 million
Market Forecast in 2032(Value)
US$ 306 million
CAGR
9.2%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Antithrombogenic Heparin Coating market is projected to grow from US$ 167 million in 2025 to US$ 306 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Antithrombogenic heparin coating refers to a layer of heparin that is applied to the surface of medical devices. Heparin is a glycosaminoglycan with a high negative charge density. It is a natural anticoagulant substance that can prevent blood from clotting. The heparin used in coatings usually has a certain purity and molecular weight range to ensure its anticoagulant effect.
From a downstream perspective, Catheters accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
Antithrombogenic Heparin Coating leading manufacturers (including Carmeda AB (Gore), Biointeractions, Medtronic, Surmodics, Corline, Toyobo, jMedtech, Biosurf, etc.), dominate supply; the top five capture approximately % of global revenue, with Carmeda AB (Gore) leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Antithrombogenic Heparin Coating market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Carmeda AB (Gore)
- Biointeractions
- Medtronic
- Surmodics
- Corline
- Toyobo
- jMedtech
- Biosurf
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Covalently Bonded Coatings
- Physisorption Coatings
Segment by Application
- Catheters
- Stents
- Implants
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Antithrombogenic Heparin Coating study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Antithrombogenic Heparin Coating: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Antithrombogenic Heparin Coating Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Covalently Bonded Coatings
1.2.3 Physisorption Coatings
1.3 Market Segmentation by Application
1.3.1 Global Antithrombogenic Heparin Coating Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Catheters
1.3.3 Stents
1.3.4 Implants
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Antithrombogenic Heparin Coating Revenue Estimates and Forecasts (2021-2032)
2.2 Global Antithrombogenic Heparin Coating Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Antithrombogenic Heparin Coating Sales Estimates and Forecasts (2021-2032)
2.4 Global Antithrombogenic Heparin Coating Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)
3 Competitive Landscape
3.1 Global Antithrombogenic Heparin Coating Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Antithrombogenic Heparin Coating Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Covalently Bonded Coatings: Market Share by Key Manufacturers
3.5.2 Physisorption Coatings: Market Share by Key Manufacturers
3.6 Global Antithrombogenic Heparin Coating Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global Antithrombogenic Heparin Coating Sales Performance by Type
4.1.1 Global Antithrombogenic Heparin Coating Sales Volume by Type (2021-2032)
4.1.2 Global Antithrombogenic Heparin Coating Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Product Technology Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Antithrombogenic Heparin Coating Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Antithrombogenic Heparin Coating Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Antithrombogenic Heparin Coating Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Antithrombogenic Heparin Coating Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Antithrombogenic Heparin Coating Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Antithrombogenic Heparin Coating Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Antithrombogenic Heparin Coating Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Antithrombogenic Heparin Coating Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Antithrombogenic Heparin Coating Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Antithrombogenic Heparin Coating Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Antithrombogenic Heparin Coating Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Antithrombogenic Heparin Coating Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Carmeda AB (Gore)
11.1.1 Carmeda AB (Gore) Corporation Information
11.1.2 Carmeda AB (Gore) Business Overview
11.1.3 Carmeda AB (Gore) Antithrombogenic Heparin Coating Product Models, Descriptions and Specifications
11.1.4 Carmeda AB (Gore) Antithrombogenic Heparin Coating Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Carmeda AB (Gore) Antithrombogenic Heparin Coating Sales by Product in 2025
11.1.6 Carmeda AB (Gore) Antithrombogenic Heparin Coating Sales by Application in 2025
11.1.7 Carmeda AB (Gore) Antithrombogenic Heparin Coating Sales by Geographic Area in 2025
11.1.8 Carmeda AB (Gore) Antithrombogenic Heparin Coating SWOT Analysis
11.1.9 Carmeda AB (Gore) Recent Developments
11.2 Biointeractions
11.2.1 Biointeractions Corporation Information
11.2.2 Biointeractions Business Overview
11.2.3 Biointeractions Antithrombogenic Heparin Coating Product Models, Descriptions and Specifications
11.2.4 Biointeractions Antithrombogenic Heparin Coating Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Biointeractions Antithrombogenic Heparin Coating Sales by Product in 2025
11.2.6 Biointeractions Antithrombogenic Heparin Coating Sales by Application in 2025
11.2.7 Biointeractions Antithrombogenic Heparin Coating Sales by Geographic Area in 2025
11.2.8 Biointeractions Antithrombogenic Heparin Coating SWOT Analysis
11.2.9 Biointeractions Recent Developments
11.3 Medtronic
11.3.1 Medtronic Corporation Information
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Antithrombogenic Heparin Coating Product Models, Descriptions and Specifications
11.3.4 Medtronic Antithrombogenic Heparin Coating Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Medtronic Antithrombogenic Heparin Coating Sales by Product in 2025
11.3.6 Medtronic Antithrombogenic Heparin Coating Sales by Application in 2025
11.3.7 Medtronic Antithrombogenic Heparin Coating Sales by Geographic Area in 2025
11.3.8 Medtronic Antithrombogenic Heparin Coating SWOT Analysis
11.3.9 Medtronic Recent Developments
11.4 Surmodics
11.4.1 Surmodics Corporation Information
11.4.2 Surmodics Business Overview
11.4.3 Surmodics Antithrombogenic Heparin Coating Product Models, Descriptions and Specifications
11.4.4 Surmodics Antithrombogenic Heparin Coating Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Surmodics Antithrombogenic Heparin Coating Sales by Product in 2025
11.4.6 Surmodics Antithrombogenic Heparin Coating Sales by Application in 2025
11.4.7 Surmodics Antithrombogenic Heparin Coating Sales by Geographic Area in 2025
11.4.8 Surmodics Antithrombogenic Heparin Coating SWOT Analysis
11.4.9 Surmodics Recent Developments
11.5 Corline
11.5.1 Corline Corporation Information
11.5.2 Corline Business Overview
11.5.3 Corline Antithrombogenic Heparin Coating Product Models, Descriptions and Specifications
11.5.4 Corline Antithrombogenic Heparin Coating Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Corline Antithrombogenic Heparin Coating Sales by Product in 2025
11.5.6 Corline Antithrombogenic Heparin Coating Sales by Application in 2025
11.5.7 Corline Antithrombogenic Heparin Coating Sales by Geographic Area in 2025
11.5.8 Corline Antithrombogenic Heparin Coating SWOT Analysis
11.5.9 Corline Recent Developments
11.6 Toyobo
11.6.1 Toyobo Corporation Information
11.6.2 Toyobo Business Overview
11.6.3 Toyobo Antithrombogenic Heparin Coating Product Models, Descriptions and Specifications
11.6.4 Toyobo Antithrombogenic Heparin Coating Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Toyobo Recent Developments
11.7 jMedtech
11.7.1 jMedtech Corporation Information
11.7.2 jMedtech Business Overview
11.7.3 jMedtech Antithrombogenic Heparin Coating Product Models, Descriptions and Specifications
11.7.4 jMedtech Antithrombogenic Heparin Coating Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 jMedtech Recent Developments
11.8 Biosurf
11.8.1 Biosurf Corporation Information
11.8.2 Biosurf Business Overview
11.8.3 Biosurf Antithrombogenic Heparin Coating Product Models, Descriptions and Specifications
11.8.4 Biosurf Antithrombogenic Heparin Coating Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Biosurf Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Antithrombogenic Heparin Coating Industry Chain
12.2 Antithrombogenic Heparin Coating Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Antithrombogenic Heparin Coating Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Antithrombogenic Heparin Coating Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Antithrombogenic Heparin Coating Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs
14 Key Findings in the Global Antithrombogenic Heparin Coating Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Antithrombogenic Heparin Coating Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Antithrombogenic Heparin Coating Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Antithrombogenic Heparin Coating Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Antithrombogenic Heparin Coating Revenue by Region (US$ Million), 2021-2026
Table 5. Global Antithrombogenic Heparin Coating Revenue by Region (US$ Million), 2027-2032
Table 6. Global Antithrombogenic Heparin Coating Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (Tons)
Table 7. Global Antithrombogenic Heparin Coating Sales by Region (Tons), 2021-2026
Table 8. Global Antithrombogenic Heparin Coating Sales by Region (Tons), 2027-2032
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 10. Global Antithrombogenic Heparin Coating Sales by Manufacturers (Tons), 2021-2026
Table 11. Global Antithrombogenic Heparin Coating Sales Share by Manufacturers (2021-2026)
Table 12. Global Antithrombogenic Heparin Coating Revenue by Manufacturers (US$ Million), 2021-2026
Table 13. Global Antithrombogenic Heparin Coating Revenue-Based Market Share by Manufacturers (2021-2026)
Table 14. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 15. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Antithrombogenic Heparin Coating Revenue, 2025
Table 16. Global Antithrombogenic Heparin Coating Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 17. Global Antithrombogenic Heparin Coating Average Selling Price (ASP) by Manufacturers (US$/Kg), 2021-2026
Table 18. Key Manufacturers Antithrombogenic Heparin Coating Manufacturing Base and Headquarters
Table 19. Global Antithrombogenic Heparin Coating Market Concentration Ratio (CR5)
Table 20. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Antithrombogenic Heparin Coating Sales Volume by Type (Tons), 2021-2026
Table 23. Global Antithrombogenic Heparin Coating Sales Volume by Type (Tons), 2027-2032
Table 24. Global Antithrombogenic Heparin Coating Revenue by Type (US$ Million), 2021-2026
Table 25. Global Antithrombogenic Heparin Coating Revenue by Type (US$ Million), 2027-2032
Table 26. Technical Specifications by Key Product Type
Table 27. Global Antithrombogenic Heparin Coating Sales by Application (Tons), 2021-2026
Table 28. Global Antithrombogenic Heparin Coating Sales by Application (Tons), 2027-2032
Table 29. Antithrombogenic Heparin Coating High-Growth Sectors Demand CAGR (2026-2032)
Table 30. Global Antithrombogenic Heparin Coating Revenue by Application (US$ Million), 2021-2026
Table 31. Global Antithrombogenic Heparin Coating Revenue by Application (US$ Million), 2027-2032
Table 32. Top Customers by Region
Table 33. Top Customers by Application
Table 34. North America Antithrombogenic Heparin Coating Growth Accelerators and Market Barriers
Table 35. North America Antithrombogenic Heparin Coating Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 36. North America Antithrombogenic Heparin Coating Sales (Tons) by Country (2021 vs 2025 vs 2032)
Table 37. Europe Antithrombogenic Heparin Coating Growth Accelerators and Market Barriers
Table 38. Europe Antithrombogenic Heparin Coating Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 39. Europe Antithrombogenic Heparin Coating Sales (Tons) by Country (2021 vs 2025 vs 2032)
Table 40. Asia-Pacific Antithrombogenic Heparin Coating Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Asia-Pacific Antithrombogenic Heparin Coating Sales (Tons) by Country (2021 vs 2025 vs 2032)
Table 42. Asia-Pacific Antithrombogenic Heparin Coating Growth Accelerators and Market Barriers
Table 43. Southeast Asia Antithrombogenic Heparin Coating Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 44. Central and South America Antithrombogenic Heparin Coating Investment Opportunities and Key Challenges
Table 45. Central and South America Antithrombogenic Heparin Coating Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. Middle East and Africa Antithrombogenic Heparin Coating Investment Opportunities and Key Challenges
Table 47. Middle East and Africa Antithrombogenic Heparin Coating Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 48. Carmeda AB (Gore) Corporation Information
Table 49. Carmeda AB (Gore) Description and Major Businesses
Table 50. Carmeda AB (Gore) Product Models, Descriptions and Specifications
Table 51. Carmeda AB (Gore) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 52. Carmeda AB (Gore) Sales Value Proportion by Product in 2025
Table 53. Carmeda AB (Gore) Sales Value Proportion by Application in 2025
Table 54. Carmeda AB (Gore) Sales Value Proportion by Geographic Area in 2025
Table 55. Carmeda AB (Gore) Antithrombogenic Heparin Coating SWOT Analysis
Table 56. Carmeda AB (Gore) Recent Developments
Table 57. Biointeractions Corporation Information
Table 58. Biointeractions Description and Major Businesses
Table 59. Biointeractions Product Models, Descriptions and Specifications
Table 60. Biointeractions Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 61. Biointeractions Sales Value Proportion by Product in 2025
Table 62. Biointeractions Sales Value Proportion by Application in 2025
Table 63. Biointeractions Sales Value Proportion by Geographic Area in 2025
Table 64. Biointeractions Antithrombogenic Heparin Coating SWOT Analysis
Table 65. Biointeractions Recent Developments
Table 66. Medtronic Corporation Information
Table 67. Medtronic Description and Major Businesses
Table 68. Medtronic Product Models, Descriptions and Specifications
Table 69. Medtronic Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 70. Medtronic Sales Value Proportion by Product in 2025
Table 71. Medtronic Sales Value Proportion by Application in 2025
Table 72. Medtronic Sales Value Proportion by Geographic Area in 2025
Table 73. Medtronic Antithrombogenic Heparin Coating SWOT Analysis
Table 74. Medtronic Recent Developments
Table 75. Surmodics Corporation Information
Table 76. Surmodics Description and Major Businesses
Table 77. Surmodics Product Models, Descriptions and Specifications
Table 78. Surmodics Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 79. Surmodics Sales Value Proportion by Product in 2025
Table 80. Surmodics Sales Value Proportion by Application in 2025
Table 81. Surmodics Sales Value Proportion by Geographic Area in 2025
Table 82. Surmodics Antithrombogenic Heparin Coating SWOT Analysis
Table 83. Surmodics Recent Developments
Table 84. Corline Corporation Information
Table 85. Corline Description and Major Businesses
Table 86. Corline Product Models, Descriptions and Specifications
Table 87. Corline Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 88. Corline Sales Value Proportion by Product in 2025
Table 89. Corline Sales Value Proportion by Application in 2025
Table 90. Corline Sales Value Proportion by Geographic Area in 2025
Table 91. Corline Antithrombogenic Heparin Coating SWOT Analysis
Table 92. Corline Recent Developments
Table 93. Toyobo Corporation Information
Table 94. Toyobo Description and Major Businesses
Table 95. Toyobo Product Models, Descriptions and Specifications
Table 96. Toyobo Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 97. Toyobo Recent Developments
Table 98. jMedtech Corporation Information
Table 99. jMedtech Description and Major Businesses
Table 100. jMedtech Product Models, Descriptions and Specifications
Table 101. jMedtech Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 102. jMedtech Recent Developments
Table 103. Biosurf Corporation Information
Table 104. Biosurf Description and Major Businesses
Table 105. Biosurf Product Models, Descriptions and Specifications
Table 106. Biosurf Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 107. Biosurf Recent Developments
Table 108. Key Raw Materials Distribution
Table 109. Raw Materials Key Suppliers
Table 110. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 111. Milestones in Production Technology Evolution
Table 112. Distributors List
Table 113. Market Trends and Market Evolution
Table 114. Market Drivers and Opportunities
Table 115. Market Challenges, Risks, and Restraints
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Antithrombogenic Heparin Coating Product Picture
Figure 2. Global Antithrombogenic Heparin Coating Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Covalently Bonded Coatings Product Picture
Figure 4. Physisorption Coatings Product Picture
Figure 5. Global Antithrombogenic Heparin Coating Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Catheters
Figure 7. Stents
Figure 8. Implants
Figure 9. Others
Figure 10. Antithrombogenic Heparin Coating Report Years Considered
Figure 11. Global Antithrombogenic Heparin Coating Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Antithrombogenic Heparin Coating Revenue (US$ Million), 2021-2032
Figure 13. Global Antithrombogenic Heparin Coating Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 14. Global Antithrombogenic Heparin Coating Revenue-Based Market Share by Region (2021-2032)
Figure 15. Global Antithrombogenic Heparin Coating Sales (Tons), 2021-2032
Figure 16. Global Antithrombogenic Heparin Coating Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (Tons)
Figure 17. Global Antithrombogenic Heparin Coating Sales Market Share by Region (2021-2032)
Figure 18. Top 5 and Top 10 Manufacturers Antithrombogenic Heparin Coating Sales Volume Market Share in 2025
Figure 19. Global Antithrombogenic Heparin Coating Revenue-Based Market Share Ranking (2025)
Figure 20. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 21. Covalently Bonded Coatings Revenue-Based Market Share by Manufacturer in 2025
Figure 22. Physisorption Coatings Revenue-Based Market Share by Manufacturer in 2025
Figure 23. Global Antithrombogenic Heparin Coating Sales Volume-Based Market Share by Type (2021-2032)
Figure 24. Global Antithrombogenic Heparin Coating Revenue-Based Market Share by Type (2021-2032)
Figure 25. Global Antithrombogenic Heparin Coating ASP by Type (US$/Kg), 2021-2032
Figure 26. Global Antithrombogenic Heparin Coating Revenue-Based Market Share (2021-2032)
Figure 27. Global Antithrombogenic Heparin Coating Sales Market Share by Application (2021-2032)
Figure 28. Global Antithrombogenic Heparin Coating Revenue-Based Market Share by Application (2021-2032)
Figure 29. Global Antithrombogenic Heparin Coating ASP by Application (US$/Kg), 2021-2032
Figure 30. North America Antithrombogenic Heparin Coating Sales YoY (Tons), 2021-2032
Figure 31. North America Antithrombogenic Heparin Coating Revenue YoY (US$ Million), 2021-2032
Figure 32. North America Top 5 Manufacturers Antithrombogenic Heparin Coating Sales Revenue (US$ Million) in 2025
Figure 33. North America Antithrombogenic Heparin Coating Sales Volume (Tons) by Application (2021-2032)
Figure 34. North America Antithrombogenic Heparin Coating Sales Revenue (US$ Million) by Application (2021-2032)
Figure 35. US Antithrombogenic Heparin Coating Revenue (US$ Million), 2021-2032
Figure 36. Canada Antithrombogenic Heparin Coating Revenue (US$ Million), 2021-2032
Figure 37. Mexico Antithrombogenic Heparin Coating Revenue (US$ Million), 2021-2032
Figure 38. Europe Antithrombogenic Heparin Coating Sales YoY (Tons), 2021-2032
Figure 39. Europe Antithrombogenic Heparin Coating Revenue YoY (US$ Million), 2021-2032
Figure 40. Europe Top 5 Manufacturers Antithrombogenic Heparin Coating Sales Revenue (US$ Million) in 2025
Figure 41. Europe Antithrombogenic Heparin Coating Sales Volume (Tons) by Application (2021-2032)
Figure 42. Europe Antithrombogenic Heparin Coating Sales Revenue (US$ Million) by Application (2021-2032)
Figure 43. Germany Antithrombogenic Heparin Coating Revenue (US$ Million), 2021-2032
Figure 44. France Antithrombogenic Heparin Coating Revenue (US$ Million), 2021-2032
Figure 45. U.K. Antithrombogenic Heparin Coating Revenue (US$ Million), 2021-2032
Figure 46. Italy Antithrombogenic Heparin Coating Revenue (US$ Million), 2021-2032
Figure 47. Russia Antithrombogenic Heparin Coating Revenue (US$ Million), 2021-2032
Figure 48. Asia-Pacific Antithrombogenic Heparin Coating Sales YoY (Tons), 2021-2032
Figure 49. Asia-Pacific Antithrombogenic Heparin Coating Revenue YoY (US$ Million), 2021-2032
Figure 50. Asia-Pacific Top 8 Manufacturers Antithrombogenic Heparin Coating Sales Revenue (US$ Million) in 2025
Figure 51. Asia-Pacific Antithrombogenic Heparin Coating Sales Volume (Tons) by Application (2021-2032)
Figure 52. Asia-Pacific Antithrombogenic Heparin Coating Sales Revenue (US$ Million) by Application (2021-2032)
Figure 53. Indonesia Antithrombogenic Heparin Coating Revenue (US$ Million), 2021-2032
Figure 54. Japan Antithrombogenic Heparin Coating Revenue (US$ Million), 2021-2032
Figure 55. South Korea Antithrombogenic Heparin Coating Revenue (US$ Million), 2021-2032
Figure 56. China Taiwan Antithrombogenic Heparin Coating Revenue (US$ Million), 2021-2032
Figure 57. India Antithrombogenic Heparin Coating Revenue (US$ Million), 2021-2032
Figure 58. Central and South America Antithrombogenic Heparin Coating Sales YoY (Tons), 2021-2032
Figure 59. Central and South America Antithrombogenic Heparin Coating Revenue YoY (US$ Million), 2021-2032
Figure 60. Central and South America Top 5 Manufacturers Antithrombogenic Heparin Coating Sales Revenue (US$ Million) in 2025
Figure 61. Central and South America Antithrombogenic Heparin Coating Sales Volume (Tons) by Application (2021-2032)
Figure 62. Central and South America Antithrombogenic Heparin Coating Sales Revenue (US$ Million) by Application (2021-2032)
Figure 63. Brazil Antithrombogenic Heparin Coating Revenue (US$ Million), 2021-2032
Figure 64. Argentina Antithrombogenic Heparin Coating Revenue (US$ Million), 2021-2032
Figure 65. Middle East, and Africa Antithrombogenic Heparin Coating Sales YoY (Tons), 2021-2032
Figure 66. Middle East and Africa Antithrombogenic Heparin Coating Revenue YoY (US$ Million), 2021-2032
Figure 67. Middle East and Africa Top 5 Manufacturers Antithrombogenic Heparin Coating Sales Revenue (US$ Million) in 2025
Figure 68. Middle East and Africa Antithrombogenic Heparin Coating Sales Volume (Tons) by Application (2021-2032)
Figure 69. Middle East and Africa Antithrombogenic Heparin Coating Sales Revenue (US$ Million) by Application (2021-2032)
Figure 70. GCC Countries Antithrombogenic Heparin Coating Revenue (US$ Million), 2021-2032
Figure 71. Turkey Antithrombogenic Heparin Coating Revenue (US$ Million), 2021-2032
Figure 72. Egypt Antithrombogenic Heparin Coating Revenue (US$ Million), 2021-2032
Figure 73. South Africa Antithrombogenic Heparin Coating Revenue (US$ Million), 2021-2032
Figure 74. Antithrombogenic Heparin Coating Industry Chain Mapping
Figure 75. Regional Antithrombogenic Heparin Coating Manufacturing Base Distribution (%)
Figure 76. Global Antithrombogenic Heparin Coating Production Market Share by Region (2021-2032)
Figure 77. Antithrombogenic Heparin Coating Production Process
Figure 78. Regional Antithrombogenic Heparin Coating Production Cost Structure
Figure 79. Channels of Distribution (Direct Vs Distribution)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Antithrombogenic Heparin Coating in 2032?
The global market size of Antithrombogenic Heparin Coating in 2032 was 306 Million USD.
What is the annual compound growth rate of the global Antithrombogenic Heparin Coating market size from 2026 to 2032?
Which region is expected to have the highest market share?
Which companies rank high in the global Antithrombogenic Heparin Coating market?
What was the global market size of Antithrombogenic Heparin Coating in 2026?
Related Reports
Global Antithrombogenic Heparin Coating Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Antithrombogenic Heparin Coating market size was US$ 167 million in 2025 and is forecast to reach a readjusted size of US$ 306 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 80
USD 4250.00
(Single User License)
Antithrombogenic Heparin Coating- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Antithrombogenic Heparin Coating was estimated to be worth US$ 167 million in 2025 and is projected to reach US$ 306 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 107
USD 3950.00
(Single User License)
Global Antithrombogenic Heparin Coating Market Research Report 2026
The global Antithrombogenic Heparin Coating market was valued at US$ 167 million in 2025 and is anticipated to reach US$ 306 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 114
USD 2900.00
(Single User License)
Global Antithrombogenic Heparin Coating Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Antithrombogenic Heparin Coating market size was US$ 154 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 79
USD 4250.00
(Single User License)
Global Antithrombogenic Heparin Coating Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Antithrombogenic Heparin Coating market is projected to grow from US$ 154 million in 2024 to US$ 283 million by 2031, at a CAGR of 9.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 148
USD 4900.00
(Single User License)
Antithrombogenic Heparin Coating - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Antithrombogenic Heparin Coating was estimated to be worth US$ 154 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 96
USD 3950.00
(Single User License)
Global Antithrombogenic Heparin Coating Market Research Report 2025
The global market for Antithrombogenic Heparin Coating was valued at US$ 154 million in the year 2024 and is projected to reach a revised size of US$ 283 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Published Date: 2025-03-10
Pages: 87
USD 2900.00
(Single User License)
Global Antithrombogenic Heparin Coating Market Research Report 2024
The global market for Antithrombogenic Heparin Coating was valued at US$ 142 million in the year 2023 and is projected to reach a revised size of US$ 261 million by 2030, growing at a CAGR of 9.2% during the forecast period.
Published Date: 2024-12-15
Pages: 86
USD 2900.00
(Single User License)
Global and United States Antithrombogenic Heparin Coating Market Report & Forecast 2024-2030
The global Antithrombogenic Heparin Coating revenue was US$ 142 million in 2023 and is forecast to a readjusted size of US$ 261 million by 2030 with a CAGR of 9.2% during the review period (2024-2030).
Published Date: 2024-12-15
Pages: 119
USD 4350.00
(Single User License)
Global Antithrombogenic Heparin Coating Market Insights, Forecast to 2030
Valued at US$ 154 million in 2024, the global Antithrombogenic Heparin Coating market is forecast to reach US$ 261 million by 2030, at a CAGR of 9.2% during the forecast period.
Published Date: 2024-12-15
Pages: 135
USD 4900.00
(Single User License)
Global Antithrombogenic Heparin Coating Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Antithrombogenic Heparin Coating market size was US$ 167 million in 2025 and is forecast to reach a readjusted size of US$ 306 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 80
USD 4250.00 (Single User License)Antithrombogenic Heparin Coating- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Antithrombogenic Heparin Coating was estimated to be worth US$ 167 million in 2025 and is projected to reach US$ 306 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-01-19
Pages: 107
USD 3950.00 (Single User License)Global Antithrombogenic Heparin Coating Market Research Report 2026
The global Antithrombogenic Heparin Coating market was valued at US$ 167 million in 2025 and is anticipated to reach US$ 306 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 114
USD 2900.00 (Single User License)Global Antithrombogenic Heparin Coating Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Antithrombogenic Heparin Coating market size was US$ 154 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 79
USD 4250.00 (Single User License)Global Antithrombogenic Heparin Coating Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Antithrombogenic Heparin Coating market is projected to grow from US$ 154 million in 2024 to US$ 283 million by 2031, at a CAGR of 9.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 148
USD 4900.00 (Single User License)Antithrombogenic Heparin Coating - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Antithrombogenic Heparin Coating was estimated to be worth US$ 154 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 96
USD 3950.00 (Single User License)Global Antithrombogenic Heparin Coating Market Research Report 2025
The global market for Antithrombogenic Heparin Coating was valued at US$ 154 million in the year 2024 and is projected to reach a revised size of US$ 283 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Published: 2025-03-10
Pages: 87
USD 2900.00 (Single User License)Global Antithrombogenic Heparin Coating Market Research Report 2024
The global market for Antithrombogenic Heparin Coating was valued at US$ 142 million in the year 2023 and is projected to reach a revised size of US$ 261 million by 2030, growing at a CAGR of 9.2% during the forecast period.
Published: 2024-12-15
Pages: 86
USD 2900.00 (Single User License)Global and United States Antithrombogenic Heparin Coating Market Report & Forecast 2024-2030
The global Antithrombogenic Heparin Coating revenue was US$ 142 million in 2023 and is forecast to a readjusted size of US$ 261 million by 2030 with a CAGR of 9.2% during the review period (2024-2030).
Published: 2024-12-15
Pages: 119
USD 4350.00 (Single User License)Global Antithrombogenic Heparin Coating Market Insights, Forecast to 2030
Valued at US$ 154 million in 2024, the global Antithrombogenic Heparin Coating market is forecast to reach US$ 261 million by 2030, at a CAGR of 9.2% during the forecast period.
Published: 2024-12-15
Pages: 135
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now